Echo IQ has developed an AI diagnostic tool that will revolutionise the diagnosis of structural heart disease. Specifically, it is designed to reduce the incidence of undetected and misdiagnosed cardiac issues.
Studycast clients can easily leverage AI decision-support for aortic stenosis.
Immediately see aortic stenosis risk for even the most complex cases
EchoSolv™ AS puts the power of the largest global database of echocardiograms linked to mortality at your fingertips. The only AI in the world built on this database, it has been clinically shown in multiple studies to identify 100% of in-guideline severe aortic stenosis patients.
72% increased AS detection vs human only diagnosis*
Your first month is free with no impact to your workflow
Find every single in-guideline severe AS patient, including LFLG and challenging cases, every single time—directly in your Studycast workflow.
Built on an understanding of the complex interrelationships of the whole heart, EchoSolv™ AS offers you decision-support in real time.
1
Fastest AI results – Complete before you start to write your report in Studycast. EchoSolv™ results will be ready for your consideration in under 20 seconds after the study arrives on Studycast.
2
Accurate – Most comprehensive AS check on all your patients: built by cardiologists, EchoSolv’s accuracy is unparalleled.
3
Zero variability – Standardize diagnosis across age, race, sex, and comorbidities.
Trying EchoSolv™ is simple
Simply complete this form and EchoSolv™ will be turned on as soon as you’re ready. With no IT steps required on your part, a member of EchoSolv™ team will reach out to you to confirm right away.
Test EchoSolv™ on both retrospective and live studies. Each study is automatically sent, returning a DICOM image result and a pre-populated field on your Studycast report, allowing you to detect AS in workflow with confidence.
The easiest AI to use
- No per-study pricing - Review as many studies as you like for a single monthly cost
- Convenient - Review your findings any place, any time on PC, laptop or mobile phone
- Dedicated account manager - Speak to the same human to answer any question at any time
Our clinical validation
St Vincent’s Hospital, Melbourne: EchoSolv™ AS study of 8,257.
By Imelda Cotton - December 15, 2022
Read More
St Vincent’s Hospital, Sydney: EchoSolv AS Study of 9.189
Imelda Cotton - April 20, 2023
Read More
Enhanced Diagnosis of Severe Aortic Stenosis Using Artificial Intelligence: A Proof-of-Concept Study of 530,871 Echocardiograms.
By David Playford MBBS, PhD, Edward Bordin BSc, ME, Razali Mohamad BCM, ME, Simon Stewart PhD, Geoff Strange BN, PhD.
Read More
The Alarm Blares for Undertreatment of Aortic Stenosis.
Lindman B, Lowenstern A, et al.
J Am Coll Cardiol.
2022 Mar, 79 (9) 878–881.
Read More
The highest security and compliance is in place
Start your free trial today
* Study conducted at St Vincent’s Hospital of 9,189 patients also found women were 66% less likely to have been accurately diagnosed than men.
Echo IQ has developed an AI diagnostic tool that will revolutionise the diagnosis of structural heart disease. Specifically, it is designed to reduce the incidence of undetected and misdiagnosed cardiac issues.
#aiwithheart
EchoSolv™ is currently available in the US and Australia as a guideline-led decision-support tool. Full
phenotyping capabilities will be available pending FDA approval.
All rights reserved. Copyright © 2023 Echo IQ.
Designed and Developed by Brand for Brands.